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In-vivo validation of interpolation-based
phase offset correction in cardiovascular
magnetic resonance flow quantification: a
multi-vendor, multi-center study
Mark B. M. Hofman1, Manouk J. A. Rodenburg1, Karin Markenroth Bloch2,3, Beat Werner4, Jos J. M. Westenberg5,
Emanuela R. Valsangiacomo Buechel6, Robin Nijveldt7, Onno A. Spruijt8, Philip J. Kilner9, Albert C. van Rossum7 and
Peter D. Gatehouse9*
Abstract
Background: A velocity offset error in phase contrast cardiovascular magnetic resonance (CMR) imaging is a known
problem in clinical assessment of flow volumes in vessels around the heart. Earlier studies have shown that this
offset error is clinically relevant over different systems, and cannot be removed by protocol optimization. Correction
methods using phantom measurements are time consuming, and assume reproducibility of the offsets which is not
the case for all systems. An alternative previously published solution is to correct the in-vivo data in post-
processing, interpolating the velocity offset from stationary tissue within the field-of-view. This study aims to
validate this interpolation-based offset correction in-vivo in a multi-vendor, multi-center setup.
Methods: Data from six 1.5 T CMR systems were evaluated, with two systems from each of the three main vendors.
At each system aortic and main pulmonary artery 2D flow studies were acquired during routine clinical or research
examinations, with an additional phantom measurement using identical acquisition parameters. To verify the
phantom acquisition, a region-of-interest (ROI) at stationary tissue in the thorax wall was placed and compared
between in-vivo and phantom measurements. Interpolation-based offset correction was performed on the in-vivo
data, after manually excluding regions of spatial wraparound. Correction performance of different spatial orders of
interpolation planes was evaluated.
Results: A total of 126 flow measurements in 82 subjects were included. At the thorax wall the agreement between
in-vivo and phantom was − 0.2 ± 0.6 cm/s. Twenty-eight studies were excluded because of a difference at the thorax
wall exceeding 0.6 cm/s from the phantom scan, leaving 98. Before correction, the offset at the vessel as assessed in
the phantom was − 0.4 ± 1.5 cm/s, which resulted in a − 5 ± 16% error in cardiac output. The optimal order of the
interpolation correction plane was 1st order, except for one system at which a 2nd order plane was required.
Application of the interpolation-based correction revealed a remaining offset velocity of 0.1 ± 0.5 cm/s and 0 ± 5% error
in cardiac output.
Conclusions: This study shows that interpolation-based offset correction reduces the offset with comparable efficacy
as phantom measurement phase offset correction, without the time penalty imposed by phantom scans.
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Background
Measurement of blood flow is potentially an unrivalled
asset of cardiovascular magnetic resonance (CMR), and
able to measure the volume flow in large vessels by pixel
wise mapping of the velocities through planes transecting
the vessels. This should provide the most accurate mea-
surements available of aortic or pulmonary regurgitation,
cardiac output, shunt flow and, indirectly, of mitral and
tricuspid regurgitation [1, 2]. The technique applied clinic-
ally for the flow measurements is 2-dimensional (2D) cine
phase contrast velocity quantification, using a flow sensi-
tivity perpendicular to the image plane. However, phase
contrast velocity mapping remains under-used, and may
have become discredited in the eyes of some CMR users,
because even when appropriate methods of acquisition
have been used, inaccurate flow measurements can be
caused by background phase errors [1, 3].
These background phase errors result in offsets in the
velocity values, typically in the range up to 4,9 cm/s [4].
However, when velocity values are integrated over the
vessel cross-section and over time, this relatively small
velocity offset can accumulate into significant errors in
volume flow [4, 5]. In most applications around the body
these offsets can be corrected by the velocity offset as
obtained in directly surrounding stationary tissue. How-
ever, for flow assessment in the large vessels around the
heart, no stationary tissue is situated close to the vessels
and as the velocity offsets vary spatially over the image,
corrections based on distant phase (such as the LPC fil-
ter described later) are more error prone.
As flow quantification at the aorta and main pul-
monary artery are the two main applications for clin-
ical CMR velocity imaging, this study focused on 2D
phase contrast imaging of these vessels. It was shown
that the velocity offset needs to be below 0.6 cm/s for
reliable clinical CMR imaging of the volume flows,
typically to obtain an error in cardiac output below
5% [4]. Earlier studies have shown that offsets found
at different CMR systems are often larger than this
target value [3, 4, 6]. Thus, correction or reduction of
this velocity offset is needed.
The cause of the velocity offset is known. A large source
is the concomitant field (i.e. Maxwell) terms of the gradient
fields [7]. As these can be estimated by the known gradient
fields, most commercial CMR systems perform a software
correction for these effects nowadays [7]. A second
contribution arises from imperfections in the eddy currents
compensation (gradient waveform pre-emphasis) [8],
where even very minor errors can cause significant vel-
ocity offsets. More recently mechanical resonance effects
in the gradient coil resulting in vibrations are described as
a third contributing factor [9, 10].
The velocity offsets issue led to an initiative backed by
the European Association of Cardiovascular Imaging
(EACVI) CMR section of the European Society of Cardi-
ology to determine whether these offsets were a general
or more site-specific problem. The first study in this ini-
tiative showed that these offsets are generic and appar-
ent on systems of all 3 main CMR vendors: General
Electric Healthcare, Siemens Healthineers and Philips
Healthcare [4]. A second phantom study investigated
whether velocity offsets could be avoided by reducing
them below 0.6 cm/s with general protocol optimization.
In a multi-vendor setup, it was shown that the offset
problem can be reduced by protocol settings but cannot
be solved by protocol optimization alone [11].
When these offsets are present in the acquisition and
are not easily preventable with general protocol guide-
lines, they should be corrected in post-processing. A
fixed correction per CMR system cannot be used as the
offsets are dependent on many protocol parameters such
as slice orientation, and thus vary per specific acquisi-
tion. The most straightforward approach is repeating the
identical acquisition on a static phantom to determine
the offset, and subtracting the corresponding apparent
phantom velocities from those of the clinical acquisition.
This approach was performed earlier in several single
center studies [3, 6, 12]. Such a correction method as-
sumes temporal stability of the velocity offset over time.
This assumption was tested in a multi-vendor study, in
which the offset appeared to be stable for most systems,
but not for all [13]. Secondly, such a phantom offset cor-
rection is time-consuming in a busy clinical schedule as
it requires additional scanner time for every single flow
acquisition [6].
Another post- processing approach is the estimation
of the offset by using the velocity values of stationary
tissue within the field-of-view (FOV); a spatially
interpolation-based offset correction. Walker et al.
proposed an algorithm to detect stationary tissue on
a pixelwise basis within the 2D image using a thresh-
old on the standard deviation of the velocity over the
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cardiac cycle [8]. Using a mask of stationary tissue,
the velocity offset was linearly interpolated over the
FOV to give a correction at the location of the vessel
of interest. More recently, this method was recon-
firmed on a newer CMR system, again in a single
center study [14]. However, this method has never
been validated in a multi-center study across systems
from different vendors. Furthermore, there is some
debate in the literature whether linear interpolation is
the best method for this correction. Some studies applied
higher order spatial fitting over the FOV [15–17], whereas
other studies found that this resulted in a lower overall ac-
curacy for the measurement at the aorta and main pul-
monary artery [14, 18].
The main objective of this study is to validate the
interpolation-based offset correction (exactly as
described fully in reference [14] based on reference [8])
of the velocity offset errors in the aorta and pulmonary
artery within a multi-center, multi-vendor setting of
regular routine unaided clinical use of the cine
phase-contrast flow technique. A secondary objective is
to assess whether linear or higher order (curved)-spatial
interpolation is required. Finally, this study describes the
velocity error and subsequent error in cardiac output
over different CMR systems and sites.
Methods
Study inclusions
For this study, 5 sites were selected with 6 whole body
1.5 T CMR systems on which regular aorta and pulmon-
ary flow acquisitions are performed. Two systems were
included for each of the 3 main vendors, Table 1 shows
the system characteristics.
2D phase contrast studies were included from patient
studies in which aorta and/or the main pulmonary flow
assessment were obtained for either clinical indication or
within another research protocol. An inclusion criterion
was acquisition in a patient with a sinus rhythm. All data
sent to the corelab (Image Analysis section below) were
anonymized. To keep balance in the data, we aimed to in-
clude 10 studies for each vessel on each CMR system.
CMR acquisition protocol
Each site applied their local protocol for aorta or pul-
monary flow acquisitions. For this study, we applied a
minimal set of protocol requirements which are known
to generally reduce the velocity offset [4, 11], and are
clinical practice in most centers. This was to validate the
offset correction in a manner most representative for
clinical practice.
The applied technique for flow assessment was 2D
phase contrast velocity quantification with a spoiled gra-
dient echo imaging pulse sequence in cine mode with
retrospective or retrogated electrocardiographic (ECG)
triggering. Imaging was performed with table shift such
that the center of the FOV was positioned in the trans-
axial iso-center plane (i.e. at z = 0 where z = the
head-foot direction) of the scanner, as supported by the
vendor’s software in routine clinical use. The encoding
velocity (Venc) was adapted reasonably to the peak vel-
ocity Vpeak; meaning (0.8 x Vpeak) < Venc < (2 x Vpeak),
such that any velocity aliasing was resolved in post pro-
cessing. Phase errors due to Maxwell/concomitant gradi-
ent terms were corrected within the image
reconstruction, as was implemented in all the different
included CMR systems [7]. Finally, specific requirements
as advised by the vendors were included to limit gradient
slew rates (General Electric: flow optimization ‘on’. Phi-
lips: default gradient mode. Siemens: normal gradient
mode).
In order to apply the interpolation-based offset correc-
tion method the following additional protocol require-
ments were added. No offset correction filters from
vendors were applied in the image reconstruction (see
Discussion); for Philips systems the default background
phase-offset correction (‘LPC filter’) and noise clipping
were switched off. Spatial wraparound in the phase en-
coding direction was limited, with instructions that each
center should ensure a remaining ‘air gap’ preventing
phase-encode wrapped tissue from overlapping onto
other tissue in the image. Both posterior and anterior ra-
diofrequency (RF) receiver coils were enabled in the
image FOV. If, for example, only anterior RF surface
coils were enabled, the resulting low signal to noise ratio
(SNR) posteriorly limited the automatic mask calculation
in the correction. Finally for validation purposes we re-
quired a FOV set such that stationary tissue in the
thorax wall was in view.
Phantom measurements
In order to act as a reference standard for the velocity
offsets, measurements in a stationary phantom were ap-
plied. After each patient acquisition, a phantom meas-
urement with exactly the same protocol settings was
performed within 24 h. A fluid or gelatin filled stationary
phantom was imaged, with a size such that it included
both the location of the vessel of interest as well as a
part of the thorax wall. The gelatin or water phantom
was doped to shorten T1 values resulting in a signal to
noise ratio in the imaging protocol above muscular
Table 1 MR system characteristics
Vendor Type Software version System nr
Philips Ingenia / Achieva R5 / R.3.2 1/2
Siemens Avanto VB17 3/4
GE Signa HDxt / Discovery
MR 450
HD23.0 V01 / DV24.0 R01 5/6
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tissue. The phantom acquisition was either triggered on
a simulated ECG at the same rate as the patient or
otherwise at 60 beats/min. For fluid filled phantoms a 5
min waiting time was included after the phantom posi-
tioning, to ensure that no residual fluid motion was
present during the measurement. This waiting delay was
omitted in case of a gelatin filled phantom. For systems
(Philips) which showed earlier a dependency of the vel-
ocity offset on the gradient system duty cycle of preced-
ing scans [10, 13], pre-scanning was performed before
the phantom flow acquisition to ensure similar gradient
coil heating. The pre-scanning consisted of the same
MR pulse-sequences as were applied in the patient study
in the 5 min preceding the clinical flow scan.
Earlier studies have shown that due to system heating,
temporal stability of the velocity offset is perturbed in
some systems [10, 13]. This instability had the potential
to invalidate the use of the phantom as a reference
standard for the purpose of this study. It would obvi-
ously not invalidate the in vivo correction which is ob-
tained simultaneously with the clinical flow
measurement. Therefore we excluded from further ana-
lysis those studies in which the velocity offset in the
phantom did not agree with the velocity offset as ob-
served in the stationary thorax wall in the in-vivo acqui-
sitions within 0.6 cm/s (the phantom measurement
accuracy check described in detail later in Methods).
Image analysis
Initial analysis was carried out at each participating site,
where analysis of the cardiac output without offset cor-
rection was performed. An ROI at the vessel of interest
was manually set at each cardiac phase, using the magni-
tude image. By copying these ROIs to the velocity im-
ages, the time-integrated volume flow was assessed. This
analysis was performed with the regular flow analysis
packages in routine use at each site.
Subsequent analysis was performed at the core-lab
(MJAR, MBMH at VUMC, NL) as follows.
Interpolation-based offset correction method
For all in-vivo measurements an interpolation-
based offset corrected dataset was obtained. The
interpolation-based offset correction method was the
method as described by Walker et al. [8], and earlier im-
plemented for a single center study [14]. First, a pixel
mask of stationary tissue was obtained by taking the 15%
of pixels which had the lowest temporal variance of their
velocity over the cardiac cycle (Fig. 1b). This stationarity
percentile of 15% was set equal to original setting of
Walker et al. [8]. A linear (first order, tilted but not
curved) surface fit of the time-averaged velocity values
within this mask was obtained as estimation of the vel-
ocity offset field (Fig. 1c). All of the velocity maps were
corrected by subtraction of the fitted velocity offset field
from the original velocity image, creating an offset cor-
rected image series (Fig. 1d). This algorithm was imple-
mented in Matlab (The Mathworks Inc., Natick,
Massachusetts, USA).
In support of the second stated objective of this paper,
the surface fitting was also performed using not only
tilted planar surfaces (“linear fitting”) but also allowing
tilted and curved surfaces (“higher order fitting” to 3rd
order inclusive) (14).
In CMR acquisitions with phase-encode spatial wrap-
around, within the “overlapping” limit explained above,
the areas of infolding tissue were manually traced and
excluded from the image, before the 15% threshold on
number of pixels was set to obtain the mask. To make
the algorithm stable for images from all vendors, the al-
gorithm was slightly adapted, because single pixels in
the air and at the edges of the images appeared in the
mask of stationary tissue using data from some vendors.
First, to exclude zero or constant-filled pixels occurring
in some reconstructions (e.g. filling in at FOV-edges
after gradient distortion correction “image warping”),
pixels with a temporal variance of the velocity over the
cardiac cycle below 10− 6 cm/s were excluded before cre-
ating the mask. Second, to reduce sensitivity to noise
pixels in air and tissue:air boundaries, the initial thresh-
old was set above the 15%, and the resulting mask was
eroded by 1 pixel, such that the final mask fit to the sta-
tionarity percentage of 15%.
Please note that the variation of offset across the field
of view is not supported by some commercial correction
software, where a single static tissue ROI is placed and
used for correction on the strongly inadequate assump-
tion that the background correction is a constant across
the field of view (i.e. the plane in C would not be tilted
at all). That questionable method should not be con-
fused with the single ROI used for the phantom meas-
urement accuracy check explained later in the Methods
and shown in Fig. 2.
Assessment of velocity offsets
For each flow acquisition, an ROI was manually drawn at
the vessel of interest at the first cardiac phase after the
R-wave, at end-diastole (Fig. 2). The velocity offset esti-
mated by the interpolation-based offset correction method
at the position of the vessel (VIB offset correction ROI vessel) was
assessed by copying the end-diastolic vessel ROI on the fit-
ted velocity offset field of the offset correction. Subse-
quently, this ROI was copied to the phantom images,
averaging over all simulated cardiac phases, to obtain the
phantom estimation of the velocity offset for this flow ac-
quisition (Vphantom ROI vessel). Using the velocity offset value
from the phantom measurement, the initial velocity offset
error (Voffset pre correction) was determined, as well as the
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residual offset error after interpolation-based correction
(Voffset after IB correction) at the location of the aorta or main
pulmonary artery, see Eqs. 1 and 2.
Vo f fsetprecorrection ¼ VphantomROIvessel ð1Þ
Voffset after IB correction ¼ VIB offset correction ROI vessel
‐Vphantom ROI vessel
ð2Þ
The velocity sign of the velocity offsets was set such
that a positive offset resulted in an overestimation of the
cardiac output. The interpolated-based correction was
repeated with 2nd and 3rd order surface fits, besides the
original linear fit, to test the correction performances of
these different spatial orders of interpolation. Using the
assessed velocity offsets and the site’s initial cardiac out-
put measurement, the error in the clinically assessed car-
diac output was calculated. For the cardiac output
analysis, the lowest interpolation order with the required
performance (i.e. < 0.6 cm/s difference from the phan-
tom estimate) was chosen, because higher interpolation
orders make the correction more sensitive to artifacts
and noise.
Finally, we assessed the pulmonic flow/systemic flow
(Qp/Qs) ratio both with and without interpolation-based
correction in a subset of subjects (as this was not the
initial setup of this study), where both aorta and main
pulmonary artery data were obtained and which were
not suspected clinically of having shunts.
Phantom measurement accuracy check
To verify the accuracy of the phantom offset determin-
ation, a check was performed in order to make the
phantom data a valid reference. From previous studies it
was known, that offset assessment by a separate phan-
tom measurement is not a good standard in all cases
due to lack of temporal stability [10, 13]. We added
A B
D
C
Fig. 1 The velocity offset correction shown in a case of pulmonary artery (PA) flow assessment: original velocity map with the PA in cross-section
(arrow) (a), mask of stationary pixels (b), 3D graph with fitted first order plane (in black) to the velocity values in the mask (blue points) showing
the variation in background offset over the field of view (c) (see text) and corrected velocity map (d). Visually the corrected map shows that the
left to right gradient in offset has been removed. (These images are shown with a small zoom which is why no PE FOV wraparound is seen)
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additional pre-measurements in the phantom imaging
protocol to create a similar system temperature. Never-
theless, a final check in the data was performed to ex-
clude irregular phantom offset data. Therefore, a ROI
was manually placed within stationary tissue at the an-
terior thorax wall. The location was chosen avoiding
phase-encode ghosting flow artifacts arising from the
heart and great vessels (Fig. 2). We copied this ROI to
the phantom image, ensuring that the ROI was com-
pletely within the phantom. In this ROI both the velocity
offset in the in-vivo acquisition as well as the phantom
acquisition were determined, taking the averaged values
over all cardiac phases (and over the ECG-simulated car-
diac phases in the stationary phantom). Only studies
with an agreement within 0.6 cm/s between these two
values passed the phantom measurement accuracy check
and were included in the Results.
Statistical analysis
From the Methods section, it should be recalled that
the velocity offset is an average over the entire car-
diac cycle (since this is retro-gated cine imaging).
Two average values of the velocity offset for each of
the 6 systems were calculated, pre-correction and
post-correction, by averaging over the studies col-
lected on the system. These values are reported as
mean ± standard deviation. The error in the cardiac
output due to the velocity offset is expressed as a
relative error in %. Differences in mean values in
offset correction between the phantom and
interpolation-based correction were tested with a
paired Student’s t-test. Offsets were reported per sys-
tem both as mean as well as using root mean square
(RMS) values. RMS values show a better indication of
the offset in an individual subject, whereas the nor-
mal average values indicate systematic offsets in a
group of subjects. Interpolation order was judged by
calculating the root mean square error per system.
Values were compared to a target limit of 0.6 cm/s.
Differences in variance were tested with an F-test. A
p value < 0.05 was considered significant.
Results
A total of 132 studies were sent to the corelab. We ex-
cluded 6 studies; 4 showing too much spatial wrap-
around in the phase encoding direction, 1 with incorrect
phantom positioning, and 1 with the vessel not clearly in
view. The remaining 126 flow measurements in 82 sub-
jects were included; 46 male, age 43 ± 20 years.
Fifty-nine measurements were at the main pulmonary
artery, and 67 at the aorta. At 5 systems mostly clinical
patient studies were included, whereas in the remaining
site patients were included which fitted in another re-
search protocol. Within each image series, areas of
Fig. 2 Example of in-vivo images (left) with corresponding phantom images (right), with magnitude images (top) and velocity images (bottom).
The ROI’s at the vessel of interest (red), at the thorax wall (green) only for ‘the phantom measurement accuracy check’ (see Methods) and at an
area of spatial wraparound (white) are shown. The white ROI was only set in a subset of the data when limited spatial wrap around was present
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spatial wraparound in the phase encoding direction were
manually excluded in 34 flow acquisitions.
For the ROI placed in stationary tissue in the thorax
wall, there was overall (including all data) a good agree-
ment between in-vivo and phantom scan of − 0.2 ± 0.6
cm/s (Fig. 3). However, as shown on Fig. 3, in total 28
studies were excluded due to a deviation larger than 0.6
cm/s between the phantom and in-vivo scan at the
thorax wall, as defined in the Methods under phantom
measurement accuracy check. Further analysis was per-
formed with 98 studies. Table 2 shows the number of in-
clusions for the different systems.
Before correction, the offset at the vessel (Voffset pre
correction) was − 0.4 ± 1.5 cm/s, and resulted in a − 5 ±
16% error in cardiac output. 40% of the patient stud-
ies showed a Voffset pre correction at the vessel smaller
than ±0.6 cm/s, with a range of − 4.2 to 3.9 cm/s.
Figures 4 and 6 show the offset at the vessel location
and the resulting error in cardiac output for the dif-
ferent systems.
With interpolation-based correction the offsets (Voffset
after IB correction) decreased, as can be observed in Fig. 4
which shows the resulting offsets after correction using
different spatial orders of interpolation. However, this
figure is less clear for judging the optimal spatial order
of interpolation, as both the mean and deviation are
changing. In Fig. 5 the RMS error is plotted for the dif-
ferent spatial orders of interpolation. Here, it shows that
first order interpolation clearly decreases the RMS error
except for one GE system, system 6. Therefore for the
further analysis of the overall effectiveness of correction,
a first order correction was chosen for systems 1–5 and
a 2nd order correction for system 6. Separate analyses
Fig. 3 Velocity offset in a ROI of stationary tissue in the thorax wall compared to velocity as assessed in the phantom at the same location. Red
symbols show the measurement points with a difference larger than 0.6 cm/s, which are excluded for further analysis; ‘the phantom
measurement accuracy check’. For systems 1 and 4, no exclusions occurred. For other systems, the included points are shown in blue
Table 2 Number of patient studies per system
# inclusions aorta #inclusions MPA
System 1 10 (10) 10 (10)
System 2 9 (8) 9 (6)
System 3 10 (9) 10 (7)
System 4 10 (10) 10 (10)
System 5 10 (8) 5 (3)
System 6 18 (8) 15 (9)
Total 67 (53) 59 (45)
In brackets the number of inclusions with an agreement at the thorax wall
with the phantom measurement < 0.6 cm/s. MPA, main pulmonary artery
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for each vessel (main pulmonary artery/aorta) per system
gave similar results for Figs. 4 and 5. The resulting er-
rors in cardiac output are presented in Fig. 6.
After application of the interpolation-based correction
with spatial orders as described above for each system, the
remaining offset velocity (Voffset after IB correction) was 0.1 ±
0.5 cm/s (p = 0.01) and 0 ± 5% error in cardiac output
(p = 0.01), significantly smaller than before offset correc-
tion. Also the variance in offset over the subjects was
significantly less after correction (p < 0.001). 78% of the in-
dividual measurements showed remaining error below 0.6
cm/s, with remaining errors were in the range of − 1.2 to
1.4 cm/s post correction. There was no statistical difference
between the velocity offset assessed by the phantom or
interpolation-based correction (p = 0.3).
The Qp/Qs was determined in a subset of 22 subjects
which were not suspected clinically of having shunts and
with measurement data in both vessels. The Qp/Qs was
Fig. 4 Velocity offset at aorta and main pulmonary artery before (Voffset pre correction) and after offset interpolation-based correction (Voffset after IB
correction) with different orders of interpolation (mean and SD per MR system)
Fig. 5 Root mean square (RMS) error of velocity offset (all aorta and main pulmonary artery results) per CMR system before (Voffset pre correction)
and after interpolation-based offset correction (Voffset after IB correction) with different spatial orders of interpolation
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1.1 ± 0.2, 1.03 ± 0.12 (p = 0.5), 1.02 ± 0.11 (p = 0.3) for
the uncorrected, phantom-based correction, and
interpolation-based correction, respectively (with
p values tested with a paired t-test against the uncor-
rected Qp/Qs values).
Discussion
In this study we have shown that without velocity offset
correction, significant errors in cardiac output can occur
in 2D phase contrast velocity quantification in the aorta
and pulmonary artery, as reported before [1, 3, 4] and
which occurred in 60% of the included scans in this
study. The multi-vendor, multi-center setup allowed a
broader evaluation of performance of the cited method.
We validated the interpolation-based offset correction to
be accurate within 0.1 ± 0.5 cm/s, as assessed over differ-
ent centers and vendors. The interpolation-based offset
correction is at least as accurate as the phantom based
offset correction. The resulting error in cardiac output is
small enough to support reliable use of this technique in
clinical practice.
Qp/Qs ratio
Earlier studies used the more clinically oriented Qp/Qs
ratio, because this value is expected to be around 1.05 in
patients not suspected of shunts [3, 6, 19]. While Qp/Qs
was not the initial setup of this study, we further
assessed its value in an subset. We did not detect a sig-
nificant change in Qp/Qs with correction, probably due
to low numbers, but the variance over the subjects was
significantly decreased after interpolation-based correc-
tion (p = 0.01). Rigsby et al. also found inconclusive re-
sults for change in the Qp/Qs ratio in a single-center
study with a similar interpolation-based offset correction
[19], but found improvement by correction in comparing
the main pulmonary artery flow with the combined flow
in the left and right pulmonary arteries [19]. This might
be explained by the system and protocol dependence of
velocity offset errors, in that using a specific protocol on
a specific system offsets are sometimes small, as can be
seen in our results for system 4. Also Meierhofen et al.
used the Qp/Qs ratio in 24 subjects in a single center
study and concluded that, according to a normal ratio
range of 0.9–1.2 that more patients without shunts in-
correctly showed a calculated shunt after phantom-
based correction [12]. Applying that same normal range
in our study, we saw that interpolation-based correction
removed incorrect shunts in 6 cases, and created in 2
cases a shunt (which we have not checked), and there-
fore improved the overall results.
Fig. 6 Relative error in cardiac output (all aorta and main pulmonary artery results) before and after interpolation-based offset correction (mean
and SD per CMR system), with first order interpolation, except for system 6 with 2nd order interpolation
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Spatial order of interpolation
In this study we examined the order of spatial
interpolation of the offset fit to the mask pixels to the
rest of the image including pertinently the location of
the vessel of interest. The initial implementation of
Walker et al. [8] applied a linear interpolation. Others
have claimed later that higher spatial orders of
interpolation should be applied [9, 15, 16]. Lankhaar et
al. tested higher interpolation order for the pulmonary
artery in a single center study, and found that errors in-
creased for higher order fits [14]. In this study we also
found that for 5 out of 6 CMR systems the RMS velocity
error across all scans increased for 2nd order fitting
compared to linear fitting. It is not that the velocity off-
set field per se is completely linear for systems 1–5, for
in several patient studies these systems also showed off-
set fields with components of 2nd and 3rd order spatial
variations. However, by making the interpolation-based
correction operate at higher order instead of linear, the
interpolation method became more sensitive to any
other variation of the velocity error across the image
FOV, resulting in greater variability over the group of
studies as a whole. Among other factors, for
higher-order fitting the error sensitivity increases to
noise in the image, errors in the stationary mask, and
small amounts of missed spatial wrap around. Giese et
al. observed in phantom measurements that the largest
component was linear and that 2nd order correction
contributed much less [9]. Only for system 6 in our re-
sults (GE), linear interpolation increased the error and
the clearly more effective 2nd order interpolation was
applied in the final cardiac output results. A similar GE
system 5 in our results showed also a slightly smaller
RMS error by 3rd order interpolation, but we did not
apply this to the cardiac output assessment because 3rd
order interpolation makes the technique too sensitive to
other errors in this setting. An earlier study on a GE
system also included higher order terms in its correction
algorithm [16]. A possible explanation may be imperfec-
tions in the Maxwell term correction, as those show
primarily 2nd order spatial variations. Thus the
interpolation-based offset correction method would re-
quire finally some tuning depending on the CMR system
it is applied to, but this is probably a system/software
specific property that can be more generally assessed.
Finally, these conclusions are for the aorta and main
pulmonary artery, which usually are situated reasonably
near the center of the FOV, and for every measurement
the patient table was adjusted to place the FOV center in
the z = 0 plane. To reduce offsets it would be better to
put the vessel of interest at the z = 0 plane. However, this
would require user input and manufacturers did not im-
plement this. Placing the vessel of interest at the FOV
center is not desirable, as this will induce spatial
wraparound or requires a large FOV. Placing the FOV
center in the z = 0 plane can be easily implemented in
the regular workflow. For vessels further away from the
center higher order corrections might be required. This
is also the situation for velocity quantification in 4D
Flow [20]; velocity quantification in this application in-
cludes vessels further away from the isocenter. The 3D
slab of images includes more stationary tissue and spatial
information so this application may benefit from higher
order spatial interpolation depending on the specific sys-
tem [5, 20, 21], but is outside the scope of the present
study. Busch et al. published a recent study on this [17].
Setting the mask of stationary pixels
Accurate and reliable determination of the mask of sta-
tionary pixels is essential to the interpolation-based cor-
rection. Here, we set the stationarity percentile to 15%
as in the original paper of Walker et al. [8]. In the study
by Lankhaar et al. [14] this stationarity percentile was
set to 25%, but the dependency of offset error on sta-
tionarity percentile was shown to be minor in that study.
We visually checked all masks to ensure that stationary
tissue in the mask appeared on at least two sides of the
thorax. This was the case in all 98 included studies. Sec-
ondly, we checked the mask visually for the presence of
vessel or heart structures, as the genuine velocity data in
these would corrupt the fitting which should only be to
stationary tissue. We found the mask to be too large in
6 cases at 3 systems, partly due to the use of a relatively
large FOV, which caused a large number of image pixels
completely outside the subject, so in these cases a sta-
tionarity percentile of 8–10% was more reliable. How-
ever, 15% was consistently used for the main results
presented as the presence of some heart or vessel pixels
in the mask in these cases did not have any noticeable
influence on the results.
Implementation of the interpolation-based correction
The algorithm as applied in this study can be imple-
mented in an analysis package for CMR flow post-
processing, as is currently already the case for some
commercial packages. In principle, the algorithm can
run without strict supervision. Manual supervision is
still required for the exclusion of phase-encode spatial
wrap around before generating the pixel mask. Secondly,
the user would also be required to confirm that station-
ary tissue is included in the mask to both sides of the
thorax, and that moving structures of the heart and large
vessels (and occasionally great veins with slow non-
pulsatile flows) are excluded. Metallic implants are also
an increasingly common problem in clinical work with
some predictable difficulty in handling nearby pixels.
The analysis package could display the stationary pixel
mask, so the user could adjust the stationarity percentile
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as described above. Finally, it may be necessary as in this
study that the spatial order of interpolation has to be set
per CMR system.
Limitations
A limitation of the interpolation-based offset correction
is that it is sensitive to phase-encode FOV wraparound
(spatial aliasing). Ideally this should be prevented in
scanning, but this is quite a stringent limitation and
tends to increase breath-hold time, unless other se-
quence parameters are adjusted, with all their conse-
quences. If phase-encode wraparound does not reach as
far as overlapping the direct image, or overlaps only
small regions, it can be excluded manually before cor-
rection. However, any such dependence on intervention
can be an obstacle to reliable clinical use. For some pro-
tocols it can be helpful to increase the phase-encoding
FOV using parallel imaging [22], because it can be diffi-
cult to sufficiently control phase-encode aliasing, espe-
cially for the typical oblique angulation of the
cross-section of the pulmonary artery.
A second protocol optimization specific for this
interpolation-based correction is to ensure that the pos-
terior RF receiver coils are switched on, even in cases
where the vessel of interest, such as the main pulmonary
artery is in the anterior part of the thorax. The posterior
coils are not of interest for the SNR at the level of the
vessel, but they are essential to provide sufficient SNR
for the CMR signal of the stationary tissue on the pos-
terior side of the thorax.
In this study we considered only 1.5 T whole body
superconducting CMR systems. Most CMR studies are
still performed at this type of CMR system. However,
there is an increased application of 3 T for CMR. The ori-
gin of the velocity offset is within the gradient system and
its associated errors, and the overall specification of these
does not change at 3 T (because it is already close to the
limit of nerve stimulation), except that Maxwell terms are
smaller, so any imperfections in their software correction
might be expected to reduce as well. Therefore, we expect
that these results should also be valid at 3 T CMR systems.
However, another aspect in which these systems might de-
viate physically from 1.5 T is mechanical vibration, as the
mechanical force for the same gradient performance scales
with main field strength. A recent small single-center
study at 3 T found similar results as this study considering
Qp/Qs ratios [23].
Care should be taken not to interpret the specific off-
sets found in this study as definitely linked to particular
vendor models of CMR systems. In this study we used
on purpose as much as possible each site’s customary
CMR protocols, thus specific settings such as
breath-holding, typical slice orientation and measure-
ment location at the vessel of interest would be likely to
give a strong bias on the velocity offset observed using
the different CMR systems [11]. The absence of any
rigorous set of scanning parameters means that this
study cannot be applied to compare velocity offsets be-
tween CMR systems and such comparison was not part
of the study design.
Notwithstanding the above, we noticed incidentally that
the two Philips CMR systems (1,2) in this study showed a
relatively high uncorrected velocity offset. Besides the
issue of the protocol differences between sites as men-
tioned before, one should realize that some systems may
apply in their default protocols a background phase-offset
correction filter. On Philips machines this is known as the
‘LPC filter’, developed to reduce the phase offset in CMR
contrast angiography, where it is expected to reduce the
velocity offset [24]. On the other hand, there is no pub-
lished validation study for the application of this filter for
vessels around the heart. The applied filter kernel is
expected to be influenced to some unknown extent by the
presence of sufficient non-stationary tissues around the
vessel of interest. Due to the principles of the
interpolation-based offset correction and the ‘LPC filter’, a
combination of applying the LPC filter before the
interpolation-based correction is not useful to test. There-
fore, we switched the ‘LPC filter’ off on Philips systems.
Retrospective ECG gating was used in this study. In
case of unstable heart rhythms, prospective ECG gating
shows clinically more reliable measurements. In the case
of prospective ECG gating it has been shown that the
amount of velocity offset varies with the timing after the
sequence starts running in each cardiac cycle, and tends
to be larger directly after the ECG trigger [9]. The
interpolation-based offset correction should then be
implemented per cardiac phase, instead of the time-
averaged offset value as in this study. Giese et al., imple-
mented this using linear correction, but did not report
good results [9]. This might need additional validation
as the variation per phase after sequence start is highly
complex dependent on incomplete sequence spoiling
[25]. However, this is solved on newer systems as pro-
spective ECG gating keeps on running the sequence
continuously while watching the ECG. At some centres
it was not possible to set a simulated ECG to the patient
heart-rate and sometimes 60 bpm was used. Because of
the use of retrospective cine gating, we do not expect
the difference in heart rate to cause any change in the
velocity offset, between the in-vivo measurement and
the phantom measurement.
In this study, the velocity offset was assessed at the
vessel position in the first cardiac phase. In reality the
vessel position varies somewhat over the cardiac phases.
This effect was neglected, but the phantom data show
that the spatial variation of the offset in this motion
range is limited.
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The ‘phantom measurement accuracy check’ was per-
formed with a relatively small ROI. Ideally, we would
perform this check on the total mask of stationary tissue.
However, this would require a stationary phantom of the
size of a large adult thorax at all centers. Because of
practical reasons, we were compelled to use a smaller
phantom allowing only the vessel and a part of the an-
terior thorax wall to be covered by the phantom. Instead
of the phantom, the possibility of some form of “internal
validation”, for example using LV stroke volume from
cine stack, or by Qp/Qs, was limited by requiring defin-
itely normal subjects, by other well-known sources of in-
accuracy and also by having no permission to make any
extra patient acquisitions for this unfunded work.
The study protocol was open on the use of
breath-hold or non-breath-hold techniques, as well as
the precise acquisition parameters and method of posi-
tioning the measurement plane in the two vessels. Every
site applied the technique in their own regular manner
(this was necessary for recruitment at all without fund-
ing). Therefore, this study shows a realistic variability of
protocol settings, but of course this might have intro-
duced also variations between the different sites and
systems. We emphasise that the acquisition parameters
were checked as identical for each in-vivo scan and its
phantom scan, so controllable differences there were not
a source.
Even in nominally breath-hold scans, phase-encode
ghosting artefacts of the bright superficial tissues (es-
pecially fat) are often problematic, and furthermore
might sometimes be relatively constant over the car-
diac cycle (depending on a few factors not to go into
here), and so the impact of artefacts on chest wall
phase might get past the temporal variance test of
the interpolation-based correction method (which
aims to exclude flow ghosting as described in
Methods). It is uncertain whether this corrupting ef-
fect is usually small (because the subtracted reference
and velocity-encoded scans are normally almost sim-
ultaneous in terms of the respiratory motion) com-
pared to the true pixel brightness at the wall, and is
of some possible concern (as are other variations
[25]) because the background offset we seek to cor-
rect is also often small.
Finally, the subset of Qp/Qs studies was acquired at
many different centres where the placement of the aortic
plane might have varied relative to the coronary ostia,
that can require a few % correction in the ‘normal’ Qp/
Qs value.
Future
In future CMR systems, field camera measurements of
real-time effective gradient fields might enable better
compensation of phase offsets [9, 26], but this potential
advance faces significant challenges including the distri-
bution of field camera probes external to the thorax and
the insufficient SNR without averaging for enough ac-
curacy to support typical background phase errors.
Using non real-time separate calibration measurement
for this compensation would only work when the
temporal stability of the systems is good enough, so it
could be included in regular CMR maintenance
measurements.
Conclusions
This study shows that interpolation-based velocity offset
correction reduces the offset with comparable efficacy as
phantom-based offset correction, without the time penalty
imposed by separate phantom scans with their associated
concern regarding short-term thermal stability. This
method showed to be stable for 2D retrospective ECG
triggered phase-contrast velocity quantification in the
large vessels around the heart. However, some manual
intervention in the largely automated correction of patient
scans remained necessary, and the optimum spatial order
of interpolation required initial assessment for each type
of system, because linear was not always optimal.
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